An Exploratory Safety Study of 480 Biomedical Sinus Drug Depot in Adult Subjects With Chronic Sinusitis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Mometasone (Primary)
- Indications Rhinosinusitis
- Focus Adverse reactions
- Sponsors Lyra Therapeutics
- 08 Oct 2018 According to a Lyra Therapeutics media release, Richard Douglas, M.D. (Professor of Surgery at The University of Auckland, New Zealand), is the lead investigator of this trial.
- 08 Oct 2018 According to a Lyra Therapeutics media release, data from this trial was presented at the American Rhinologic Society Annual Meeting (Oct 2018).
- 08 Oct 2018 Results presented in the Lyra Therapeutics media release.